Capvizr
News · All summaries
Healthcare & Life Sciences
Tempo Therapeutics
Series B$15 million
RoundSeries B
Amount$15 million
HQSan Diego, United States
DateSeptember 16, 2026
THE DEAL, AT A GLANCE

Tempo Therapeutics

From the announcement
What happenedTempo Therapeutics raised $15M Series B, announced 2026-09-16From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Why it mattersTempo Therapeutics' $15M Series B is a below-median Healthcare & Life Sciences financing, sitting at the 20th percentile in a sector that recorded 30 other trailing…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Tempo Therapeutics · Financing Record

Explore source-linked visual explanations for Tempo Therapeutics. Unsupported claims are withheld while source review continues.

Record 12428 · Recorded date: 2026-09-16

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime